ClinicalTrials.gg
Not yet recruitingNCT07660952Updated Oct 2, 2026

Effect of IE Glasses on MRI Patient Outcomes

An interventional study of Immersive entertainment glasses and Standard of Care: Anesthesia in MRI-related Anxiety and MRI Completion Rate, sponsored by Baptist Health South Florida. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-02.

Sponsored by Baptist Health South Florida · Not applicable, Interventional, and Supportive care

Updated Oct 2, 2026Start date movedPrimary completion moved+1 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

Examine the effect of immersive entertainment glasses (IEG) on patients' claustrophobia-associated anxiety levels during magnetic resonance imaging (MRI).

02

Conditions studied

  • MRI-related Anxiety
  • MRI Completion Rate
03

In context

Lead sponsor

Baptist Health South Florida is the lead sponsor of 52 studies on the registry; 18 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 7 (78%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients at least 18 years of age
  • Outpatients/inpatients scheduled for an MRI with anesthesia
  • Inpatients scheduled for an MRI with an IV/PO sedative

Exclusion criteria

Exclusion Criteria:

  • Pregnant patients
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
300 participants (estimated)

Study arms

  • Active comparator
    Control Group 1

    Patients who receive anesthesia (general or conscious sedation) for completion of their MRI scans as ordered by the physician.

    Drug: Standard of Care: Anesthesia

  • Active comparator
    Control Group 2

    Patients who receive oral or intravenous sedation \[i.e., benzodiazepines such as lorazepam (Ativan), diazepam (Valium), alprazolam (Xanax), or equivalent\] for completion of their MRI scans, as ordered by the physician.

    Drug: Standard of Care: Sedative

  • Experimental
    Intervention Group

    Patients scheduled for MRIs with anesthesia or a sedative choose to use the immersive entertainment glasses (instead of the physician-ordered anesthesia or sedative) for completion of their MRI scans.

    Device: Immersive entertainment glasses

Interventions

  • DeviceImmersive entertainment glasses

    Use of immersive entertainment glasses during the MRI procedure.

  • DrugStandard of Care: Anesthesia

    Patient receives anesthesia as ordered by the physician.

  • DrugStandard of Care: Sedative

    Patient receives a sedative as ordered by the physician.

06

What researchers measure

Primary outcomes

  1. Anxiety relief (self-report measure 2 - Visual Analog Scale for Anxiety)

    Patient's anxiety will be measured using the Visual Analog Scale for Anxiety (VAS-A), a slider scale of 0 - 100 is used to self-report anxiety (0 = not anxious and 100 = extremely anxious), taken before and after the MRI procedure.

    Time frame: 15 to 120 minutes (depends on the duration of the MRI procedure)

  2. Anxiety relief (physiological measure - heart rate)

    Heart rate is measured before and after the MRI procedure. Increased anxiety may cause elevation of this physiological indicator.

    Time frame: 15 to 120 minutes (depends on the duration of the MRI procedure)

  3. MRI completion rate

    MRI completed successfully = yes or no

    Time frame: Immediately after the MRI procedure.

  4. MRI Image Quality

    Quality of the images as noted by the radiologist on the MRI report.

    Time frame: Immediately after the MRI procedure.

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Start date
Jul 1, 2026→Dec 1, 2026
Oct 2, 2026
Primary completion
Jul 1, 2027→Dec 1, 2027
Oct 2, 2026
Study completion
Jul 1, 2027→Dec 1, 2027
Oct 2, 2026
Show all 1 update
  1. Oct 2, 2026
    Start date Jul 1, 2026→Dec 1, 2026
    Primary completion Jul 1, 2027→Dec 1, 2027
    Study completion Jul 1, 2027→Dec 1, 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07660952
Lead sponsor
Baptist Health South Florida
Responsible party
Sponsor
First posted
Jun 22, 2026
Start date
Dec 1, 2026 (estimated)
Primary completion
Dec 1, 2027 (estimated)
Completion
Dec 1, 2027 (estimated)
Last update
Oct 2, 2026

Study contacts

Frank Boza, BSN, RN, VA-BC
Contact
frankbo@baptisthealth.net
786-662-0660
Marian Ramos, MSN, RN, CBN
Contact
marianr@baptisthealth.net
786-527-6208
Natalie Bermudez, PhD, RN, EBP-C
study chair · Baptist Health | Nursing & Health Sciences Research

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion